Kin Pan Au

Outcomes and risk of relapse after living donor and deceased donor liver transplantation for alcohol-associated liver disease

Chloe Huen Wai Choy, Hills King-Hei Suen, Tiffany Cho-Lam Wong, Miu-Yee Chan et autres

INTRODUCTION AND OBJECTIVES: The six-month abstinence rule for alcohol-associated liver disease (ALD) patients may exclude candidates from life-saving transplantation without reliably predicting relapse. We compared outcomes of deceased donor liver transplantation (DDLT) and living donor liver transplantation (LDLT) in ALD patients, with …

cn, hk (code pays fourni par la source)

Associating liver partition and portal vein ligation for staged hepatectomy in patients with hepatocellular carcinoma: laparoscopic versus open approach and its impact on future remnant hypertrophy

Kin Pan Au, Wing Chiu Dai, Allan Hoi Kin Lam, Yee Han Shum et autres

hk (code pays fourni par la source)

Survival impact of conversion therapy for Barcelona Clinic Liver Cancer (BCLC) stage B and C hepatocellular carcinoma—a propensity score matching analysis

Karin Ho, Chi‐Leung Chiang, Tiffany Wong, Wing Chiu Dai et autres

cn, hk (code pays fourni par la source)

Multiple 11C-acetate and 18fludeoxyglucose-avid hepatic tumours in a young woman: primary, secondary, or something else?

Kin Pan Au, Regina Cheuk‐Lam Lo, Ksh Chok

A 32-year-old lady presented with abdominal pain and computed tomography scan detected multifocal bilobar hepatic tumours. The tumours had heterogeneous radiological appearance. The largest tumour situated in left lateral section and was hypodense on arterial and portal venous phases. There were two …

cn, hk (code pays fourni par la source)

44eP Biologically targeted dual adaptive and innate nano-immunotherapy for clear cell renal cell carcinoma treatment

Andrew Z. Wang, Kin Pan Au, S. Li, T. Zhang

us (code pays fourni par la source)

Entecavir Monotherapy for Chronic Hepatitis B After Liver Transplantation: A 17-Year Follow-Up Study

Kin Pan Au, Megan Chan, Jun Dai, J. Fung et autres

Purpose: While previous studies from our group demonstrated excellent early outcomes with entecavir monotherapy for chronic hepatitis B (CHB) post-liver transplantation (LT), long-term data remain scarce.

hk (code pays fourni par la source)

Effects of rivaroxaban on vascular endothelial function and circulating endothelial progenitor cells: a randomized controlled trial

Miao Lin, Chun Kwok Wong, Kelvin Y.K. Chan, Florence W. L. Tsui et autres

Abstract Background Combination of low dose rivaroxaban with aspirin was shown to reduce major adverse cardiovascular events when compared to aspirin monotherapy in COMPASS trial. The beneficial effect of rivaroxaban beyond factor Xa inhibition remains unknown. Purpose This randomized controlled trial explored …

hk, cn (code pays fourni par la source)

Inferior vena cava reconstruction in extended right hepatectomy

Karin KY Ho, Sui Ling Sin, Kin Pan Au, Henry HY Lee et autres

link_to_subscribed_fulltext

hk (code pays fourni par la source)

Surgical cystogastrostomy: Is it still worthwhile?

Kin Pan Au, Ksh Chok

explores the treatment of peripancreatic fluid collection (PFC). The use of percutaneous drainage, endoscopy, and surgery for managing PFC are discussed. Percutaneous drainage is noted for its low risk profile, while endoscopic cystogastrostomy is more effective due to the wider orifice of …

cn, hk (code pays fourni par la source)

Confounders in developing a machine learning model for colorectal liver metastasis post-hepatectomy prognostications

Kin Pan Au, Tan To Cheung

hk (code pays fourni par la source)

Verifying the benefits of radical treatment in posttransplant hepatocellular carcinoma oligo-recurrence: a propensity score analysis

Kin Pan Au, James Yan Yue Fung, Wing Chiu Dai, Albert Chan et autres

Background: It is unclear whether radical treatment for hepatocellular carcinoma (HCC) oligo-recurrence after liver transplantation conveys survival benefits. Methods: A retrospective study of 144 patients with posttransplant HCC recurrence was performed. Propensity score matching was performed to adjust for baseline covariates between …

hk (code pays fourni par la source)

Impact of tumor biology on outcomes of radical therapy for hepatocellular carcinoma oligo-recurrence after liver transplantation

Kin Pan Au, James Yan Yue Fung, Wing Chiu Dai, Albert Chan et autres

Background: It is uncertain whether tumour biology affects radical treatment for posttransplant hepatocellular carcinoma (HCC) oligo-recurrence, i.e., recurrence limited in numbers and locations amendable to radical therapy.

hk (code pays fourni par la source)